Erlotinib Associated Trichomegaly in a Patient with Chronic Latanoprost Use
Journal Title: Journal of Hematology and Oncology Research - Year 2015, Vol 1, Issue 4
Abstract
Trichomegaly is a known adverse effect with the epidermal growth factor receptor inhibitor (EGFRI) and prostaglandin analogue drug classes. We present a chronic Latanoprost user who developed symptomatic trichomegaly subsequent to initiating an EGFRI medication and believe this case offers evidence that the two classes of medications may cause a similar eyelash manifestation through different mechanisms.
Authors and Affiliations
Burris CK, Richards NQ, Cowan CL Jr
Keywords
Related Articles
- EP ID EP249482
- DOI 10.14302/issn.2372-6601.jhor-15-667
- Views 227
- Downloads 0
Study of Neuropilin-1/Cd304 Expression in Leukemogenesis
Neuropilins are transmembrane glycoproteins that act as receptors for vascular endothelial growth factors (VEGF) and are involved in the process of tumor angiogenesis. Its importance in hematological malignancies such as...
Early Detection of Post-transplant Lymphoproliferative Disorder by Head and Neck Manifestations
Introduction: Post-transplant lymphoproliferative disease (PTLD) is a collection of conditions associated with abnormal proliferation of lymphoid tissues in patients after solid organ transplants (SOT). Its clinical pre...
Itraconazole Prophylaxis for an Outbreak of Invasive Aspergillosis in a Hematology Ward after Hospital Construction Work
Objective: Hospital construction work, among other environmental factors, is a risk factor for invasive aspergillosis (IA). Methods: We retrospectively surveyed the incidence of IA in hematology-oncology patients befo...
Morphological and Functional Abnormalities of the Thyroid Gland among End Stage Kidney Disease Patients
Several interactions exist between thyroid and kidney function in many disorders. Many publications explored the relationship between thyroid diseases (TD) and chronic kidney diseases (CKD). However, the morphological th...
Combination of Radiation Therapy and Immunotherapy in the Treatment of Melanoma
Melanoma is considered to be a very aggressive cancer due to its rapid growth, early and multiple metastases and limited response to standard treatment. Many researchers have hypothesized that the combination of radiatio...